Pasar al contenido principal

SINERGIAS EN EL ESTUDIO GENETICO Y LA BUSQUEDA DE TERAPIAS PARA EL SINDROME DE OPITZ C, LA FRACTURA FEMORAL ATIPICA, LA OSTEOPOROSIS Y ENFERMEDADES LISOSOMALES

SAF2016-75948-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2016
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 23
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Effect of the tumor suppressor miR-320a on viability and functionality of human osteosarcoma cell Llnes compared to primary osteoblasts

  • Ugarte Corbalán, Laura de, 1988-
  • Balcells, Susana
  • Güerri Fernández, Roberto
  • Grinberg, Daniel
  • Diez Pérez, Adolfo
  • Nogués Solán, Xavier
  • Garcia Giralt, Natàlia
The miR-320a regulates a number of genes involved in various physiological processes. In particular, it has been reported as a tumor suppressor in several types of human cancers and involved in osteoporotic fracture and osteoblast function. Hence, the role of miR-320a has been evaluated in tumor cells and in primary cells in a separated context, but its effect has never been explored in a comparative manner. The present study aims to evaluate the cellular effects of miR-320a on human osteosarcoma cell lines (MG-63 and U2OS) compared to that on primary human osteoblasts (hOBs). miR-320a was either overexpressed or inhibited in all cell lines, and cell proliferation and viability were analyzed. Additionally, the effects of miR-320a on matrix mineralization, alkaline phosphatase activity, and oxidative stress were also evaluated in order to assess osteoblast functionality. In osteosarcoma cells, miR-320a overexpression reduced cell viability and proliferation, while in hOB cell viability was not affected and proliferation even was increased. The overexpression of miR-320a in both osteosarcoma cells and hOBs reduced the mineralization capacity. Finally, an increased oxidative stress was detected in all cells after miR-320a overexpression mainly in osteosarcoma. In conclusion, the overexpression of miR-320a increased stress oxidation levels, which could be involved in the reduced osteoblast performance, even though the cell viability was only affected in osteosarcoma cells., This research was supported by the CIBER on Frailty and Healthy Ageing (CIBERFES; grant number: CB16/10/00245), the CIBERER (grant number: U720), FEDER funds, and grants from the Science and Innovation Ministry (ISCIII; grant numbers: PI16/01860 and PI13/00116; SAF2016-75948-R). L.D.-U. was granted with a PFIS predoctoral fellowship from the ISCIII.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Evolutionary and functional analyses of LRP5 in archaic and extant modern humans

  • Roca Ayats, Neus
  • Maceda Porto, Iago, 1986-
  • Bruque, Carlos David
  • Martínez-Gil, Núria
  • Garcia Giralt, Natàlia
  • Cozar, Mónica
  • Mellibovsky, Leonardo
  • Van Hul, Wim
  • Lao Grueso, Oscar, 1976-
  • Grinberg, Daniel
  • Balcells, Susana
Background: The human lineage has undergone a postcranial skeleton gracilization (i.e. lower bone mass and strength relative to body size) compared to other primates and archaic populations such as the Neanderthals. This gracilization has been traditionally explained by differences in the mechanical load that our ancestors exercised. However, there is growing evidence that gracilization could also be genetically influenced. Results: We have analyzed the LRP5 gene, which is known to be associated with high bone mineral density conditions, from an evolutionary and functional point of view. Taking advantage of the published genomes of archaic Homo populations, our results suggest that this gene has a complex evolutionary history both between archaic and living humans and within living human populations. In particular, we identified the presence of different selective pressures in archaics and extant modern humans, as well as evidence of positive selection in the African and South East Asian populations from the 1000 Genomes Project. Furthermore, we observed a very limited evidence of archaic introgression in this gene (only at three haplotypes of East Asian ancestry out of the 1000 Genomes), compatible with a general erasing of the fingerprint of archaic introgression due to functional differences in archaics compared to extant modern humans. In agreement with this hypothesis, we observed private mutations in the archaic genomes that we experimentally validated as putatively increasing bone mineral density. In particular, four of five archaic missense mutations affecting the first β-propeller of LRP5 displayed enhanced Wnt pathway activation, of which two also displayed reduced negative regulation. Conclusions: In summary, these data suggest a genetic component contributing to the understanding of skeletal differences between extant modern humans and archaic Homo populations., NRA, NMG, MC, DG and SB acknowledge the financial support from Spanish Ministry of Science and Innovation (SAF 2016-75948R and PID2019-107188RB-C21) and Catalan Government (2017SGR:00738). NRA was a recipient of a FPU predoctoral fellowship from the Spanish Minsterio de Educación Cultura y Deporte. NMG was a recipient of a FI predoctoral fellowship from AGAUR (Catalan Agency for Management of University and Research Grants). OL and IM acknowledge the support from Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa, CERCA Program/Generalitat de Catalunya, Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III, Generalitat de Catalunya through Departament de Salut and Departament d’Empresa i Coneixement, Co-financing with funds from the European Regional Development Fund by the Spanish Ministry of Science and Innovation corresponding to the Programa Operativo FEDER Plurirregional de España (POPE) 2014–2020 and by the Secretaria d’Universitats i Recerca, Departament d’Empresa i Coneixement of the Generalitat de Catalunya corresponding to the Programa Operatiu FEDER de Catalunya 2014–2020. OL gratefully acknowledges the financial support from Ministerio de Economía y Competitividad (Ministry of Economy and Competitiveness) PGC2018-098574-B-I00, Generalitat de Catalunya (Government of Catalonia)—GRC 2017 SGR 937 and CSIC (Proyecto Intramural 2022). IM gratefully acknowledges the financial support from the Government of Catalonia | Agència de Gestió d’Ajuts Universitaris i de Recerca (Agency for Management of University and Research Grants)—GRC 2014 SGR 615.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Functional characterization of the C7ORF76 genomic region, a prominent GWAS signal for osteoporosis in 7q21.3

  • Roca Ayats, Neus
  • Martínez-Gil, Núria
  • Cozar, Mónica
  • Gerousi, Marina
  • Garcia Giralt, Natàlia
  • Ovejero Crespo, Diana
  • Mellibovsky, Leonardo
  • Nogués Solán, Xavier
  • Díez Pérez, Adolfo
  • Grinberg, Daniel
  • Balcells, Susana
Genome-wide association studies (GWAS) have repeatedly identified genetic variants associated with bone mineral density (BMD) and osteoporotic fracture in non-coding regions of C7ORF76, a poorly studied gene of unknown function. The aim of the present study was to elucidate the causality and molecular mechanisms underlying the association. We re-sequenced the genomic region in two extreme BMD groups from the BARCOS cohort of postmenopausal women to search for functionally relevant variants. Eight selected variants were tested for association in the complete cohort and 2 of them (rs4342521 and rs10085588) were found significantly associated with lumbar spine BMD and nominally associated with osteoporotic fracture. cis-eQTL analyses of these 2 SNPs, together with SNP rs4727338 (GWAS lead SNP in Estrada et al., Nat Genet. 44:491-501, 2012), performed in human primary osteoblasts, disclosed a statistically significant influence on the expression of the proximal neighbouring gene SLC25A13 and a tendency on the distal SHFM1. We then studied the functionality of a putative upstream regulatory element (UPE), containing rs10085588. Luciferase reporter assays showed transactivation capability with a strong allele-dependent effect. Finally, 4C-seq experiments in osteoblastic cell lines showed that the UPE interacted with different tissue-specific enhancers and a lncRNA (LOC100506136) in the region. In summary, this study is the first one to analyse in depth the functionality of C7ORF76 genomic region. We provide functional regulatory evidence for the rs10085588, which may be a causal SNP within the 7q21.3 GWAS signal for osteoporosis., This work was supported by the following grants: SAF2014-56562-R, SAF2016-75948-R (Spanish MINECO), 2014SGR932 (Generalitat de Catalunya), CIBERER (U720), and FEIOMM Investigación 2014. NRA is a recipient of an FPU predoctoral fellowship from the Spanish Ministerio de Educación, Cultura y Deporte; NMG is a recipient of a FI predoctoral fellowship from Generalitat de Catalunya.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Functional characterization of a GGPPS variant identified in atypical femoral fracture patients and delineation of the role of GGPPS in bone-relevant cell types

  • Roca Ayats, Neus
  • Ng, Pei Ying
  • Garcia Giralt, Natàlia
  • Falcó-Mascaró, Maite
  • Cozar, Mónica
  • Abril Ferrando, Josep Francesc
  • Quesada-Gómez, J.M.
  • Prieto-Alhambra, Daniel
  • Nogués Solán, Xavier
  • Dunford, James E.
  • Russell, R. Graham
  • Baron, Roland
  • Grinberg, Daniel
  • Balcells, Susana
  • Díez Pérez, Adolfo
Atypical femoral fractures (AFFs) are a rare but potentially devastating event, often but not always linked to bisphosphonate (BP) therapy. The pathogenic mechanisms underlying AFFs remain obscure, and there are no tests available that might assist in identifying those at high risk of AFF. We previously used exome sequencing to explore the genetic background of three sisters with AFFs and three additional unrelated AFF cases, all previously treated with BPs. We detected 37 rare mutations (in 34 genes) shared by the three sisters. Notably, we found a p.Asp188Tyr mutation in the enzyme geranylgeranyl pyrophosphate synthase, a component of the mevalonate pathway, which is critical to osteoclast function and is inhibited by N-BPs. In addition, the CYP1A1 gene, responsible for the hydroxylation of 17β-estradiol, estrone, and vitamin D, was also mutated in all three sisters and one unrelated patient. Here we present a detailed list of the variants found and report functional analyses of the GGPS1 p.Asp188Tyr mutation, which showed a severe reduction in enzyme activity together with oligomerization defects. Unlike BP treatment, this genetic mutation will affect all cells in the carriers. RNAi knockdown of GGPS1 in osteoblasts produced a strong mineralization reduction and a reduced expression of osteocalcin, osterix, and RANKL, whereas in osteoclasts, it led to a lower resorption activity. Taken together, the impact of the mutated GGPPS and the relevance of the downstream effects in bone cells make it a strong candidate for AFF susceptibility. We speculate that other genes such as CYP1A1 might be involved in AFF pathogenesis, which remains to be functionally proved. The identification of the genetic background for AFFs provides new insights for future development of novel risk assessment tools., We thank the patients for their kind participation. Funds for the study include grants SAF2014‐56562R, SAF2016‐75948‐R (Spanish MINECO), PI12/02315 (FIS, ISCII), 2014SGR932 (Catalan Government), and CIBERER (U720). This work was also supported by the Centro de Investigación Biomédica en Red en Fragilidad y Envejecimiento Saludable (CIBERFES; CB16/10/00245) and FEDER funds. JED was supported by the NIHR Biomedical Research Centre, Oxford, UK. NR is recipient of an FPU predoctoral fellowship from the Spanish Ministerio de Educación Cultura y Deporte. The work was also supported by a grant from the US government, NIH, NIAMS (R01 AR062054) to RB.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Functional assessment of coding and regulatory variants from the DKK1 locus

  • Martínez-Gil, Núria
  • Roca Ayats, Neus
  • Atalay, Nurgül
  • Pineda-Moncusí, Marta
  • Garcia Giralt, Natàlia
  • Van Hul, Wim
  • Boudin, Eveline
  • Ovejero Crespo, Diana
  • Mellibovsky, Leonardo
  • Nogués Solán, Xavier
  • Diez Pérez, Adolfo
  • Grinberg, Daniel
  • Balcells, Susana
The DKK1 gene encodes an extracellular inhibitor of the Wnt pathway with an important role in bone tissue development, bone homeostasis, and different critical aspects of bone biology. Several BMD genome-wide association studies (GWASs) have consistently found association with SNPs in the DKK1 genomic region. For these reasons, it is important to assess the functionality of coding and regulatory variants in the gene. Here, we have studied the functionality of putative regulatory variants, previously found associated with BMD in different studies by others and ourselves, and also six missense variants present in the general population. Using a Wnt-pathway-specific luciferase reporter assay, we have determined that the variants p.Ala41Thr, p.Tyr74Phe, p.Arg120Leu, and p.Ser157Ile display a reduced DKK1 inhibitory capacity as compared with WT. This result agrees with the high-bone-mass (HBM) phenotype of two women from our cohort who carried mutations p.Tyr74Phe or p.Arg120Leu. On the other hand, by means of a circularized chromosome conformation capture- (4C-) sequencing experiment, we have detected that the region containing 24 BMD-GWA variants, located 350-kb downstream of DKK1, interacts both with DKK1 and the LNCAROD (LncRNA-activating regulator of DKK1, AKA LINC0148) in osteoblastic cells. In conclusion, we have shown that some rare coding variants are partial loss-of-function mutations that may lead to a HBM phenotype, whereas the common SNPs associated with BMD in GWASs belong to a putative long-range regulatory region, through a yet unknown mechanism involving LNCAROD. © 2020 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research., Funds for the study included grants SAF2014‐56562‐R and SAF2016‐75948‐R (Spanish MINECO), and CIBERER (U720). NMG is a recipient of a FI predoctoral fellowship from AGAUR (Generalitat de Catalunya); NRA is a recipient of a FPU predoctoral fellowship from the Spanish Ministerio de Educación Cultura y Deporte. EB is a recipient of a postdoctoral fellowship (12A3814N) from the Research Foundation‐Flanders. We thank O. Monclús and M. Cozar for relevant technical assistance. Authorsʼ roles: NMG, WVH, DG, SB were involved in the study conception and design. Material preparation and data collection were performed by NMG, NRA, NA, NGG, EB, DO, LM, XN, and ADP. The analyses were performed by NMG. The statistical analyses were performed by MPM. The first draft of the manuscript was written by NMG, DG, SB, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

A roadmap to gene discoveries and novel therapies in monogenic low and high bone mass disorders

  • Formosa, Melissa M.
  • Bergen, Dylan J.M.
  • Gregson, Celia L.
  • Maurizi, Antonio
  • Kämpe, Anders
  • Garcia Giralt, Natàlia
  • Zhou, Wei
  • Grinberg, Daniel
  • Ovejero Crespo, Diana
  • Zillikens, M. Carola
  • Williams, Graham R.
  • Bassett, J.H. Duncan
  • Brandi, María Luisa
  • Sangiorgi, Luca
  • Balcells, Susana
  • Högler, Wolfgang
  • Van Hul, Wim
  • Mäkitie, Outi
Genetic disorders of the skeleton encompass a diverse group of bone diseases differing in clinical characteristics, severity, incidence and molecular etiology. Of particular interest are the monogenic rare bone mass disorders, with the underlying genetic defect contributing to either low or high bone mass phenotype. Extensive, deep phenotyping coupled with high-throughput, cost-effective genotyping is crucial in the characterization and diagnosis of affected individuals. Massive parallel sequencing efforts have been instrumental in the discovery of novel causal genes that merit functional validation using in vitro and ex vivo cell-based techniques, and in vivo models, mainly mice and zebrafish. These translational models also serve as an excellent platform for therapeutic discovery, bridging the gap between basic science research and the clinic. Altogether, genetic studies of monogenic rare bone mass disorders have broadened our knowledge on molecular signaling pathways coordinating bone development and metabolism, disease inheritance patterns, development of new and improved bone biomarkers, and identification of novel drug targets. In this comprehensive review we describe approaches to further enhance the innovative processes taking discoveries from clinic to bench, and then back to clinic in rare bone mass disorders. We highlight the importance of cross laboratory collaboration to perform functional validation in multiple model systems after identification of a novel disease gene. We describe the monogenic forms of rare low and high rare bone mass disorders known to date, provide a roadmap to unravel the genetic determinants of monogenic rare bone mass disorders using proper phenotyping and genotyping methods, and describe different genetic validation approaches paving the way for future treatments., Funding was obtained from the GEMSTONE COST Action (CA18139). MMF has received research funds from The University of Malta Research, Innovation and Development Trust and The Malta Community Chest Fund, and the Research Excellence Programme (REP-2020-011; Project GeOM financed by the Malta Council for Science & Technology, for and on behalf of the Foundation for Science and Technology, through the Research Excellence Programme). DB is funded by the Foundation Fellowship from Versus Arthritis (Grant no. 22044). NG-G and DC are supported by CIBERFES (CB16/10/00245 [ISCIII]), FEIOMM2019 and European Regional Development Fund (ERDF). WZ is funded by the Jaap Schouten Foundation (The Netherlands). WVH received a Methusalem-OEC grant for the project “GENOMED” and a Research Fund of the University of Antwerp (FFB190208). MB has received funding from La Fondazione Italiana Ricerca sulle Malattie dell’Osso. The Origins of Bone and Cartilage Disease Programme analysed the skeletal phenotype of knockout mice generated by the International Mouse Phenotyping Consortium (IMPC) and was funded by a Wellcome Trust Strategic Award (101123) to GW and JB. OM is funded by the Sigrid Jusélius Foundation. DG and SB declare that this study received funding from MINECO (SAF2016-75948R and PID2019-107188RB-C21). The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Genetic analysis in a familial case with high bone mineral density suggests additive effects at two loci

  • Martínez-Gil, Núria
  • Ovejero Crespo, Diana
  • Garcia Giralt, Natàlia
  • Bruque, Carlos David
  • Mellibovsky, Leonardo
  • Nogués Solán, Xavier
  • Rabionet Janssen, Raquel
  • Grinberg, Daniel
  • Balcells, Susana
Osteoporosis is the most common bone disease, characterized by a low bone mineral density (BMD) and increased risk of fracture. At the other end of the BMD spectrum, some individuals present strong, fracture-resistant, bones. Both osteoporosis and high BMD are heritable and their genetic architecture encompasses polygenic inheritance of common variants and some cases of monogenic highly penetrant variants in causal genes. We have investigated the genetics of high BMD in a family segregating this trait in an apparently Mendelian dominant pattern. We searched for rare causal variants by whole-exome sequencing in three affected and three nonaffected family members. Using this approach, we have identified 38 rare coding variants present in the proband and absent in the three individuals with normal BMD. Although we have found four variants shared by the three affected members of the family, we have not been able to relate any of these to the high-BMD phenotype. In contrast, we have identified missense variants in two genes, VAV3 and ADGRE5, each shared by two of out of three affected members, whose loss of function fits with the phenotype of the family. In particular, the proband, a woman displaying the highest BMD (sum Z-score = 7), carries both variants, whereas the other two affected members carry one each. VAV3 encodes a guanine-nucleotide-exchange factor with an important role in osteoclast activation and function. Although no previous cases of VAV3 mutations have been reported in humans, Vav3 knockout (KO) mice display dense bones, similarly to the high-BMD phenotype present in our family. The ADGRE5 gene encodes an adhesion G protein-coupled receptor expressed in osteoclasts whose KO mouse displays increased trabecular bone volume. Combined, these mouse and human data highlight VAV3 and ADGRE5 as novel putative high-BMD genes with additive effects, and potential therapeutic targets for osteoporosis. © 2022 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research., Funds for the study include grants SAF2016-75948-R (Spanish MINECO), PID2019-107188RB-C21 (MICINN) and CIBERER (U720), CIBERFES (CB16/10/00245), and European Regional Development Fund for the whole project. We thank Mónica Cózar for technical assistance and the family for their enthusiastic participation.Authors' roles: NMG was involved in conceptualization, data curation, formal analysis, investigation, methodology, writing-original draft, and review & editing. CDB was involved in data curation, formal analysis, methodology, and review & editing. RR, DG, and SB were involved in conceptualization, funding acquisition, investigation, supervision, writing-original draft, and review & editing. DO and NGG were involved in investigation, data curation, and writing-review & editing. XN and LM were involved in conceptualization, data curation, and writing-review & editing.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Common and rare variants of WNT16, DKK1 and SOST and their relationship with bone mineral density

  • Martínez-Gil, Núria
  • Roca Ayats, Neus
  • Monistrol-Mula, Anna
  • Garcia Giralt, Natàlia
  • Diez Pérez, Adolfo
  • Nogués Solán, Xavier
  • Mellibovsky, Leonardo
  • Grinberg, Daniel
  • Balcells, Susana
Numerous GWAS and candidate gene studies have highlighted the role of the Wnt pathway in bone biology. Our objective has been to study in detail the allelic architecture of three Wnt pathway genes: WNT16, DKK1 and SOST, in the context of osteoporosis. We have resequenced the coding and some regulatory regions of these three genes in two groups with extreme bone mineral density (BMD) (n = ∼50, each) from the BARCOS cohort. No interesting novel variants were identified. Thirteen predicted functional variants have been genotyped in the full cohort (n = 1490), and for ten of them (with MAF > 0.01), the association with BMD has been studied. We have found six variants nominally associated with BMD, of which 2 WNT16 variants predicted to be eQTLs for FAM3C (rs55710688, in the Kozak sequence and rs142005327, within a putative enhancer) withstood multiple-testing correction. In addition, two rare variants in functional regions (rs190011371 in WNT16b 3'UTR and rs570754792 in the SOST TATA box) were found only present in three women each, all with BMD below the mean of the cohort. Our results reinforce the higher importance of regulatory versus coding variants in these Wnt pathway genes and open new ways for functional studies of the relevant variants., We thank M. Pineda, N. Stender, R. Urreizti and M. Cozar for relevant technical assistance. Funds for the study include grants SAF2014-56562-R and SAF2016-75948-R (Spanish MINECO), and CIBERER (U720). NMG is a recipient of a FI predoctoral fellowship from Generalitat de Catalunya; NRA is a recipient of a FPU predoctoral fellowship from the Spanish Ministerio de Educación Cultura y Deporte.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Expression profiling of microRNAs in human bone tissue from postmenopausal women

  • Ugarte Corbalán, Laura de, 1988-
  • Serra-Vinardell, Jenny
  • Nonell Mazelon, Lara, 1972-
  • Balcells, Susana
  • Arnal, Magdalena
  • Nogués Solán, Xavier
  • Mellibovsky, Leonardo
  • Grinberg, Daniel
  • Díez Pérez, Adolfo
  • Garcia Giralt, Natàlia
Bone tissue is composed of several cell types, which express their own microRNAs (miRNAs) that will play a role in cell function. The set of total miRNAs expressed in all cell types configures the specific signature of the bone tissue in one physiological condition. The aim of this study was to explore the miRNA expression profile of bone tissue from postmenopausal women. Tissue was obtained from trabecular bone and was analyzed in fresh conditions (n = 6). Primary osteoblasts were also obtained from trabecular bone (n = 4) and human osteoclasts were obtained from monocyte precursors after in vitro differentiation (n = 5). MicroRNA expression profiling was obtained for each sample by microarray and a global miRNA analysis was performed combining the data acquired in all the microarray experiments. From the 641 miRNAs detected in bone tissue samples, 346 (54%) were present in osteoblasts and/or osteoclasts. The other 46% were not identified in any of the bone cells analyzed. Intersection of osteoblast and osteoclast arrays identified 101 miRNAs shared by both cell types, which accounts for 30-40% of miRNAs detected in these cells. In osteoblasts, 266 miRNAs were detected, of which 243 (91%) were also present in the total bone array, representing 38% of all bone miRNAs. In osteoclasts, 340 miRNAs were detected, of which 196 (58%) were also present in the bone tissue array, representing 31% of all miRNAs detected in total bone. These analyses provide an overview of miRNAs expressed in bone tissue, broadening our knowledge in the microRNA field., This work was supported by the Red Temática de Investigación Cooperativa en Envejecimiento y Fragilidad (RETICEF; RD12/0043/0022) and Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES; CB16/10/00245), and the Grants PI10/01537, PI13/00116, and PI13/00444 from FIS (Carlos III Health Institute, Science and Innovation Ministry); SAF2016-75948-R, from Ministerio de Economia y Competitividad, and 2014SGR-932 from Generalitat de Catalunya. FEDER funds also supported this study.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

A de novo FOXP1 truncating mutation in a patient originally diagnosed as C syndrome

  • Urreizti, Roser
  • Damanti, Sarah
  • Esteve, Carla
  • Franco Valls, Héctor
  • Castilla-Vallmanya, Laura
  • Tonda, Raúl
  • Cormand, Bru
  • Vilageliu, Lluïsa
  • Opitz, John M.
  • Neri, Giovanni
  • Grinberg, Daniel
  • Balcells, Susana
De novo FOXP1 mutations have been associated with intellectual disability (ID), motor delay, autistic features and a wide spectrum of speech difficulties. C syndrome (Opitz C trigonocephaly syndrome) is a rare and genetically heterogeneous condition, characterized by trigonocephaly, craniofacial anomalies and ID. Several different chromosome deletions and and point mutations in distinct genes have been associated with the disease in patients originally diagnosed as Opitz C. By whole exome sequencing we identified a de novo splicing mutation in FOXP1 in a patient, initially diagnosed as C syndrome, who suffers from syndromic intellectual disability with trigonocephaly. The mutation (c.1428 + 1 G > A) promotes the skipping of exon 16, a frameshift and a premature STOP codon (p.Ala450GLyfs*13), as assessed by a minigene strategy. The patient reported here shares speech difficulties, intellectual disability and autistic features with other FOXP1 syndrome patients, and thus the diagnosis for this patient should be changed. Finally, since trigonocephaly has not been previously reported in FOXP1 syndrome, it remains to be proved whether it may be associated with the FOXP1 mutation., The authors thank the patient and his family for wholehearted collaboration. They are also grateful to M. Cozar for technical assistance, and to CNAG for exome sequencing within the “300 exomes to elucidate rare diseases” program. Funding was from Associació Síndrome Opitz C, Terrassa, Spain; Spanish Ministerio de Economía y Competitividad (SAF2014-56562-R; SAF2016-75948-R, FECYT, crowdfunding PRECIPITA); ISCIII Ministerio de Economía y Competitividad (PT13/0001/0044), Catalan Government (2014SGR932) and from CIBERER (U720).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Five new cases of syndromic intellectual disability due to KAT6A mutations: widening the molecular and clinical spectrum

  • Urreizti, Roser
  • López Martín, Estrella
  • Martínez Monseny, Antonio Federico
  • Pujadas, Montserrat
  • Castilla-Vallmanya, Laura
  • Pérez Jurado, Luis Alberto
  • Serrano, Mercedes
  • Natera de Benito, Daniel
  • Martínez Delgado, Beatriz
  • Posada de la Paz, Manuel
  • Alonso, Javier
  • Marín Reina, Purificación
  • O'Callaghan, Mar
  • Grinberg, Daniel
  • Bermejo Sánchez, Eva
  • Balcells, Susana
Background: Pathogenic variants of the lysine acetyltransferase 6A or KAT6A gene are associated with a newly identified neurodevelopmental disorder characterized mainly by intellectual disability of variable severity and speech delay, hypotonia, and heart and eye malformations. Although loss of function (LoF) mutations were initially reported as causing this disorder, missense mutations, to date always involving serine residues, have recently been associated with a form of the disorder without cardiac involvement. Results: In this study we present five new patients, four with truncating mutations and one with a missense change and the only one not presenting with cardiac anomalies. The missense change [p.(Gly359Ser)], also predicted to affect splicing by in silico tools, was functionally tested in the patient’s lymphocyte RNA revealing a splicing effect for this allele that would lead to a frameshift and premature truncation. Conclusions: An extensive revision of the clinical features of these five patients revealed high concordance with the 80 cases previously reported, including developmental delay with speech delay, feeding difficulties, hypotonia, a high bulbous nose, and recurrent infections. Other features present in some of these five patients, such as cryptorchidism in males, syndactyly, and trigonocephaly, expand the clinical spectrum of this syndrome., Funding was from Associació Síndrome Opitz C, Terrassa, Spain; Spanish Ministerio de Economía y Competitividad (SAF2016–75948-R) and from CIBERER (U720). SpainUDP is an initiative funded by the Instituto de Salud Carlos III. Also, the whole exome sequencing of patient 3 was funded through 2016 BBMRI-LPC Call (FP7/2007–2013, grant agreement n° 313010) and patient 5 was sequenced thanks to the PERIS·URDCat program, funded by the Departament de Salut de la Generalitat de Catalunya (PERIS_SLT002_16_00174).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Evolutionary and functional analyses of LRP5 in archaic and extant modern humans

  • Roca-Ayats, Neus
  • Maceda, Iago
  • Bruque, Carlos David
  • Martínez-Gil, Núria
  • Garcia-Giralt, Natàlia
  • Cozar, Mónica
  • Mellibovsky, Leonardo
  • Van Hul, Wim
  • Lao, Oscar
  • Grinberg, Daniel
  • Balcells, Susanna
[Background] The human lineage has undergone a postcranial skeleton gracilization (i.e. lower bone mass and strength relative to body size) compared to other primates and archaic populations such as the Neanderthals. This gracilization has been traditionally explained by differences in the mechanical load that our ancestors exercised. However, there is growing evidence that gracilization could also be genetically influenced., [Results] We have analyzed the LRP5 gene, which is known to be associated with high bone mineral density conditions, from an evolutionary and functional point of view. Taking advantage of the published genomes of archaic Homo populations, our results suggest that this gene has a complex evolutionary history both between archaic and living humans and within living human populations. In particular, we identified the presence of different selective pressures in archaics and extant modern humans, as well as evidence of positive selection in the African and South East Asian populations from the 1000 Genomes Project. Furthermore, we observed a very limited evidence of archaic introgression in this gene (only at three haplotypes of East Asian ancestry out of the 1000 Genomes), compatible with a general erasing of the fingerprint of archaic introgression due to functional differences in archaics compared to extant modern humans. In agreement with this hypothesis, we observed private mutations in the archaic genomes that we experimentally validated as putatively increasing bone mineral density. In particular, four of five archaic missense mutations affecting the first β-propeller of LRP5 displayed enhanced Wnt pathway activation, of which two also displayed reduced negative regulation., [Conclusions] In summary, these data suggest a genetic component contributing to the understanding of skeletal differences between extant modern humans and archaic Homo populations., NRA, NMG, MC, DG and SB acknowledge the financial support from Spanish Ministry of Science and Innovation (SAF 2016-75948R and PID2019-107188RB-C21) and Catalan Government (2017SGR:00738). NRA was a recipient of a FPU predoctoral fellowship from the Spanish Ministerio de Educación Cultura y Deporte. NMG was a recipient of a FI predoctoral fellowship from AGAUR (Catalan Agency for Management of University and Research Grants). OL and IM acknowledge the support from Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa, CERCA Program/Generalitat de Catalunya, Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III, Generalitat de Catalunya through Departament de Salut and Departament d’Empresa i Coneixement, Co-financing with funds from the European Regional Development Fund by the Spanish Ministry of Science and Innovation corresponding to the Programa Operativo FEDER Plurirregional de España (POPE) 2014–2020 and by the Secretaria d’Universitats i Recerca, Departament d’Empresa i Coneixement of the Generalitat de Catalunya corresponding to the Programa Operatiu FEDER de Catalunya 2014–2020. OL gratefully acknowledges the financial support from Ministerio de Economía y Competitividad (Ministry of Economy and Competitiveness) PGC2018-098574-B-I00, Generalitat de Catalunya (Government of Catalonia)—GRC 2017 SGR 937 and CSIC (Proyecto Intramural 2022). IM gratefully acknowledges the financial support from the Government of Catalonia | Agència de Gestió d’Ajuts Universitaris i de Recerca (Agency for Management of University and Research Grants)—GRC 2014 SGR 615., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Effect of the tumor suppressor miR-320a on viability and functionality of human osteosarcoma cell Llnes compared to primary osteoblasts

  • Ugarte Corbalán, Laura de, 1988-
  • Balcells, Susana
  • Güerri Fernández, Roberto
  • Grinberg, Daniel
  • Diez Pérez, Adolfo
  • Nogués Solán, Xavier
  • Garcia Giralt, Natàlia
The miR-320a regulates a number of genes involved in various physiological processes. In particular, it has been reported as a tumor suppressor in several types of human cancers and involved in osteoporotic fracture and osteoblast function. Hence, the role of miR-320a has been evaluated in tumor cells and in primary cells in a separated context, but its effect has never been explored in a comparative manner. The present study aims to evaluate the cellular effects of miR-320a on human osteosarcoma cell lines (MG-63 and U2OS) compared to that on primary human osteoblasts (hOBs). miR-320a was either overexpressed or inhibited in all cell lines, and cell proliferation and viability were analyzed. Additionally, the effects of miR-320a on matrix mineralization, alkaline phosphatase activity, and oxidative stress were also evaluated in order to assess osteoblast functionality. In osteosarcoma cells, miR-320a overexpression reduced cell viability and proliferation, while in hOB cell viability was not affected and proliferation even was increased. The overexpression of miR-320a in both osteosarcoma cells and hOBs reduced the mineralization capacity. Finally, an increased oxidative stress was detected in all cells after miR-320a overexpression mainly in osteosarcoma. In conclusion, the overexpression of miR-320a increased stress oxidation levels, which could be involved in the reduced osteoblast performance, even though the cell viability was only affected in osteosarcoma cells., This research was supported by the CIBER on Frailty and Healthy Ageing (CIBERFES; grant number: CB16/10/00245), the CIBERER (grant number: U720), FEDER funds, and grants from the Science and Innovation Ministry (ISCIII; grant numbers: PI16/01860 and PI13/00116; SAF2016-75948-R). L.D.-U. was granted with a PFIS predoctoral fellowship from the ISCIII.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Functional characterization of a GGPPS variant identified in atypical femoral fracture patients and delineation of the role of GGPPS in bone-relevant cell types

  • Roca Ayats, Neus
  • Ng, Pei Ying
  • Garcia Giralt, Natàlia
  • Falcó-Mascaró, Maite
  • Cozar, Mónica
  • Abril Ferrando, Josep Francesc
  • Quesada-Gómez, J.M.
  • Prieto-Alhambra, Daniel
  • Nogués Solán, Xavier
  • Dunford, James E.
  • Russell, R. Graham
  • Baron, Roland
  • Grinberg, Daniel
  • Balcells, Susana
  • Díez Pérez, Adolfo
Atypical femoral fractures (AFFs) are a rare but potentially devastating event, often but not always linked to bisphosphonate (BP) therapy. The pathogenic mechanisms underlying AFFs remain obscure, and there are no tests available that might assist in identifying those at high risk of AFF. We previously used exome sequencing to explore the genetic background of three sisters with AFFs and three additional unrelated AFF cases, all previously treated with BPs. We detected 37 rare mutations (in 34 genes) shared by the three sisters. Notably, we found a p.Asp188Tyr mutation in the enzyme geranylgeranyl pyrophosphate synthase, a component of the mevalonate pathway, which is critical to osteoclast function and is inhibited by N-BPs. In addition, the CYP1A1 gene, responsible for the hydroxylation of 17β-estradiol, estrone, and vitamin D, was also mutated in all three sisters and one unrelated patient. Here we present a detailed list of the variants found and report functional analyses of the GGPS1 p.Asp188Tyr mutation, which showed a severe reduction in enzyme activity together with oligomerization defects. Unlike BP treatment, this genetic mutation will affect all cells in the carriers. RNAi knockdown of GGPS1 in osteoblasts produced a strong mineralization reduction and a reduced expression of osteocalcin, osterix, and RANKL, whereas in osteoclasts, it led to a lower resorption activity. Taken together, the impact of the mutated GGPPS and the relevance of the downstream effects in bone cells make it a strong candidate for AFF susceptibility. We speculate that other genes such as CYP1A1 might be involved in AFF pathogenesis, which remains to be functionally proved. The identification of the genetic background for AFFs provides new insights for future development of novel risk assessment tools., We thank the patients for their kind participation. Funds for the study include grants SAF2014‐56562R, SAF2016‐75948‐R (Spanish MINECO), PI12/02315 (FIS, ISCII), 2014SGR932 (Catalan Government), and CIBERER (U720). This work was also supported by the Centro de Investigación Biomédica en Red en Fragilidad y Envejecimiento Saludable (CIBERFES; CB16/10/00245) and FEDER funds. JED was supported by the NIHR Biomedical Research Centre, Oxford, UK. NR is recipient of an FPU predoctoral fellowship from the Spanish Ministerio de Educación Cultura y Deporte. The work was also supported by a grant from the US government, NIH, NIAMS (R01 AR062054) to RB.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Functional characterization of the C7ORF76 genomic region, a prominent GWAS signal for osteoporosis in 7q21.3

  • Roca Ayats, Neus
  • Martínez-Gil, Núria
  • Cozar, Mónica
  • Gerousi, Marina
  • Garcia Giralt, Natàlia
  • Ovejero Crespo, Diana
  • Mellibovsky, Leonardo
  • Nogués Solán, Xavier
  • Díez Pérez, Adolfo
  • Grinberg, Daniel
  • Balcells, Susana
Genome-wide association studies (GWAS) have repeatedly identified genetic variants associated with bone mineral density (BMD) and osteoporotic fracture in non-coding regions of C7ORF76, a poorly studied gene of unknown function. The aim of the present study was to elucidate the causality and molecular mechanisms underlying the association. We re-sequenced the genomic region in two extreme BMD groups from the BARCOS cohort of postmenopausal women to search for functionally relevant variants. Eight selected variants were tested for association in the complete cohort and 2 of them (rs4342521 and rs10085588) were found significantly associated with lumbar spine BMD and nominally associated with osteoporotic fracture. cis-eQTL analyses of these 2 SNPs, together with SNP rs4727338 (GWAS lead SNP in Estrada et al., Nat Genet. 44:491-501, 2012), performed in human primary osteoblasts, disclosed a statistically significant influence on the expression of the proximal neighbouring gene SLC25A13 and a tendency on the distal SHFM1. We then studied the functionality of a putative upstream regulatory element (UPE), containing rs10085588. Luciferase reporter assays showed transactivation capability with a strong allele-dependent effect. Finally, 4C-seq experiments in osteoblastic cell lines showed that the UPE interacted with different tissue-specific enhancers and a lncRNA (LOC100506136) in the region. In summary, this study is the first one to analyse in depth the functionality of C7ORF76 genomic region. We provide functional regulatory evidence for the rs10085588, which may be a causal SNP within the 7q21.3 GWAS signal for osteoporosis., This work was supported by the following grants: SAF2014-56562-R, SAF2016-75948-R (Spanish MINECO), 2014SGR932 (Generalitat de Catalunya), CIBERER (U720), and FEIOMM Investigación 2014. NRA is a recipient of an FPU predoctoral fellowship from the Spanish Ministerio de Educación, Cultura y Deporte; NMG is a recipient of a FI predoctoral fellowship from Generalitat de Catalunya.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Functional assessment of coding and regulatory variants from the DKK1 locus

  • Martínez-Gil, Núria
  • Roca Ayats, Neus
  • Atalay, Nurgül
  • Pineda-Moncusí, Marta
  • Garcia Giralt, Natàlia
  • Van Hul, Wim
  • Boudin, Eveline
  • Ovejero Crespo, Diana
  • Mellibovsky, Leonardo
  • Nogués Solán, Xavier
  • Diez Pérez, Adolfo
  • Grinberg, Daniel
  • Balcells, Susana
The DKK1 gene encodes an extracellular inhibitor of the Wnt pathway with an important role in bone tissue development, bone homeostasis, and different critical aspects of bone biology. Several BMD genome-wide association studies (GWASs) have consistently found association with SNPs in the DKK1 genomic region. For these reasons, it is important to assess the functionality of coding and regulatory variants in the gene. Here, we have studied the functionality of putative regulatory variants, previously found associated with BMD in different studies by others and ourselves, and also six missense variants present in the general population. Using a Wnt-pathway-specific luciferase reporter assay, we have determined that the variants p.Ala41Thr, p.Tyr74Phe, p.Arg120Leu, and p.Ser157Ile display a reduced DKK1 inhibitory capacity as compared with WT. This result agrees with the high-bone-mass (HBM) phenotype of two women from our cohort who carried mutations p.Tyr74Phe or p.Arg120Leu. On the other hand, by means of a circularized chromosome conformation capture- (4C-) sequencing experiment, we have detected that the region containing 24 BMD-GWA variants, located 350-kb downstream of DKK1, interacts both with DKK1 and the LNCAROD (LncRNA-activating regulator of DKK1, AKA LINC0148) in osteoblastic cells. In conclusion, we have shown that some rare coding variants are partial loss-of-function mutations that may lead to a HBM phenotype, whereas the common SNPs associated with BMD in GWASs belong to a putative long-range regulatory region, through a yet unknown mechanism involving LNCAROD. © 2020 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research., Funds for the study included grants SAF2014‐56562‐R and SAF2016‐75948‐R (Spanish MINECO), and CIBERER (U720). NMG is a recipient of a FI predoctoral fellowship from AGAUR (Generalitat de Catalunya); NRA is a recipient of a FPU predoctoral fellowship from the Spanish Ministerio de Educación Cultura y Deporte. EB is a recipient of a postdoctoral fellowship (12A3814N) from the Research Foundation‐Flanders. We thank O. Monclús and M. Cozar for relevant technical assistance. Authorsʼ roles: NMG, WVH, DG, SB were involved in the study conception and design. Material preparation and data collection were performed by NMG, NRA, NA, NGG, EB, DO, LM, XN, and ADP. The analyses were performed by NMG. The statistical analyses were performed by MPM. The first draft of the manuscript was written by NMG, DG, SB, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Evolutionary and functional analyses of LRP5 in archaic and extant modern humans

  • Roca Ayats, Neus
  • Maceda Porto, Iago, 1986-
  • Bruque, Carlos David
  • Martínez-Gil, Núria
  • Garcia Giralt, Natàlia
  • Cozar, Mónica
  • Mellibovsky, Leonardo
  • Van Hul, Wim
  • Lao Grueso, Oscar, 1976-
  • Grinberg, Daniel
  • Balcells, Susana
Background: The human lineage has undergone a postcranial skeleton gracilization (i.e. lower bone mass and strength relative to body size) compared to other primates and archaic populations such as the Neanderthals. This gracilization has been traditionally explained by differences in the mechanical load that our ancestors exercised. However, there is growing evidence that gracilization could also be genetically influenced. Results: We have analyzed the LRP5 gene, which is known to be associated with high bone mineral density conditions, from an evolutionary and functional point of view. Taking advantage of the published genomes of archaic Homo populations, our results suggest that this gene has a complex evolutionary history both between archaic and living humans and within living human populations. In particular, we identified the presence of different selective pressures in archaics and extant modern humans, as well as evidence of positive selection in the African and South East Asian populations from the 1000 Genomes Project. Furthermore, we observed a very limited evidence of archaic introgression in this gene (only at three haplotypes of East Asian ancestry out of the 1000 Genomes), compatible with a general erasing of the fingerprint of archaic introgression due to functional differences in archaics compared to extant modern humans. In agreement with this hypothesis, we observed private mutations in the archaic genomes that we experimentally validated as putatively increasing bone mineral density. In particular, four of five archaic missense mutations affecting the first β-propeller of LRP5 displayed enhanced Wnt pathway activation, of which two also displayed reduced negative regulation. Conclusions: In summary, these data suggest a genetic component contributing to the understanding of skeletal differences between extant modern humans and archaic Homo populations., NRA, NMG, MC, DG and SB acknowledge the financial support from Spanish Ministry of Science and Innovation (SAF 2016-75948R and PID2019-107188RB-C21) and Catalan Government (2017SGR:00738). NRA was a recipient of a FPU predoctoral fellowship from the Spanish Minsterio de Educación Cultura y Deporte. NMG was a recipient of a FI predoctoral fellowship from AGAUR (Catalan Agency for Management of University and Research Grants). OL and IM acknowledge the support from Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa, CERCA Program/Generalitat de Catalunya, Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III, Generalitat de Catalunya through Departament de Salut and Departament d’Empresa i Coneixement, Co-financing with funds from the European Regional Development Fund by the Spanish Ministry of Science and Innovation corresponding to the Programa Operativo FEDER Plurirregional de España (POPE) 2014–2020 and by the Secretaria d’Universitats i Recerca, Departament d’Empresa i Coneixement of the Generalitat de Catalunya corresponding to the Programa Operatiu FEDER de Catalunya 2014–2020. OL gratefully acknowledges the financial support from Ministerio de Economía y Competitividad (Ministry of Economy and Competitiveness) PGC2018-098574-B-I00, Generalitat de Catalunya (Government of Catalonia)—GRC 2017 SGR 937 and CSIC (Proyecto Intramural 2022). IM gratefully acknowledges the financial support from the Government of Catalonia | Agència de Gestió d’Ajuts Universitaris i de Recerca (Agency for Management of University and Research Grants)—GRC 2014 SGR 615.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Genetic analysis in a familial case with high bone mineral density suggests additive effects at two loci

  • Martínez-Gil, Núria
  • Ovejero Crespo, Diana
  • Garcia Giralt, Natàlia
  • Bruque, Carlos David
  • Mellibovsky, Leonardo
  • Nogués Solán, Xavier
  • Rabionet Janssen, Raquel
  • Grinberg, Daniel
  • Balcells, Susana
Osteoporosis is the most common bone disease, characterized by a low bone mineral density (BMD) and increased risk of fracture. At the other end of the BMD spectrum, some individuals present strong, fracture-resistant, bones. Both osteoporosis and high BMD are heritable and their genetic architecture encompasses polygenic inheritance of common variants and some cases of monogenic highly penetrant variants in causal genes. We have investigated the genetics of high BMD in a family segregating this trait in an apparently Mendelian dominant pattern. We searched for rare causal variants by whole-exome sequencing in three affected and three nonaffected family members. Using this approach, we have identified 38 rare coding variants present in the proband and absent in the three individuals with normal BMD. Although we have found four variants shared by the three affected members of the family, we have not been able to relate any of these to the high-BMD phenotype. In contrast, we have identified missense variants in two genes, VAV3 and ADGRE5, each shared by two of out of three affected members, whose loss of function fits with the phenotype of the family. In particular, the proband, a woman displaying the highest BMD (sum Z-score = 7), carries both variants, whereas the other two affected members carry one each. VAV3 encodes a guanine-nucleotide-exchange factor with an important role in osteoclast activation and function. Although no previous cases of VAV3 mutations have been reported in humans, Vav3 knockout (KO) mice display dense bones, similarly to the high-BMD phenotype present in our family. The ADGRE5 gene encodes an adhesion G protein-coupled receptor expressed in osteoclasts whose KO mouse displays increased trabecular bone volume. Combined, these mouse and human data highlight VAV3 and ADGRE5 as novel putative high-BMD genes with additive effects, and potential therapeutic targets for osteoporosis. © 2022 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research., Funds for the study include grants SAF2016-75948-R (Spanish MINECO), PID2019-107188RB-C21 (MICINN) and CIBERER (U720), CIBERFES (CB16/10/00245), and European Regional Development Fund for the whole project. We thank Mónica Cózar for technical assistance and the family for their enthusiastic participation.Authors' roles: NMG was involved in conceptualization, data curation, formal analysis, investigation, methodology, writing-original draft, and review & editing. CDB was involved in data curation, formal analysis, methodology, and review & editing. RR, DG, and SB were involved in conceptualization, funding acquisition, investigation, supervision, writing-original draft, and review & editing. DO and NGG were involved in investigation, data curation, and writing-review & editing. XN and LM were involved in conceptualization, data curation, and writing-review & editing.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Five new cases of syndromic intellectual disability due to KAT6A mutations: widening the molecular and clinical spectrum

  • Urreizti, Roser
  • López Martín, Estrella
  • Martínez Monseny, Antonio Federico
  • Pujadas, Montserrat
  • Castilla-Vallmanya, Laura
  • Pérez Jurado, Luis Alberto
  • Serrano, Mercedes
  • Natera de Benito, Daniel
  • Martínez Delgado, Beatriz
  • Posada de la Paz, Manuel
  • Alonso, Javier
  • Marín Reina, Purificación
  • O'Callaghan, Mar
  • Grinberg, Daniel
  • Bermejo Sánchez, Eva
  • Balcells, Susana
Background: Pathogenic variants of the lysine acetyltransferase 6A or KAT6A gene are associated with a newly identified neurodevelopmental disorder characterized mainly by intellectual disability of variable severity and speech delay, hypotonia, and heart and eye malformations. Although loss of function (LoF) mutations were initially reported as causing this disorder, missense mutations, to date always involving serine residues, have recently been associated with a form of the disorder without cardiac involvement. Results: In this study we present five new patients, four with truncating mutations and one with a missense change and the only one not presenting with cardiac anomalies. The missense change [p.(Gly359Ser)], also predicted to affect splicing by in silico tools, was functionally tested in the patient’s lymphocyte RNA revealing a splicing effect for this allele that would lead to a frameshift and premature truncation. Conclusions: An extensive revision of the clinical features of these five patients revealed high concordance with the 80 cases previously reported, including developmental delay with speech delay, feeding difficulties, hypotonia, a high bulbous nose, and recurrent infections. Other features present in some of these five patients, such as cryptorchidism in males, syndactyly, and trigonocephaly, expand the clinical spectrum of this syndrome., Funding was from Associació Síndrome Opitz C, Terrassa, Spain; Spanish Ministerio de Economía y Competitividad (SAF2016–75948-R) and from CIBERER (U720). SpainUDP is an initiative funded by the Instituto de Salud Carlos III. Also, the whole exome sequencing of patient 3 was funded through 2016 BBMRI-LPC Call (FP7/2007–2013, grant agreement n° 313010) and patient 5 was sequenced thanks to the PERIS·URDCat program, funded by the Departament de Salut de la Generalitat de Catalunya (PERIS_SLT002_16_00174).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A de novo FOXP1 truncating mutation in a patient originally diagnosed as C syndrome

  • Urreizti, Roser
  • Damanti, Sarah
  • Esteve, Carla
  • Franco Valls, Héctor
  • Castilla-Vallmanya, Laura
  • Tonda, Raúl
  • Cormand, Bru
  • Vilageliu, Lluïsa
  • Opitz, John M.
  • Neri, Giovanni
  • Grinberg, Daniel
  • Balcells, Susana
De novo FOXP1 mutations have been associated with intellectual disability (ID), motor delay, autistic features and a wide spectrum of speech difficulties. C syndrome (Opitz C trigonocephaly syndrome) is a rare and genetically heterogeneous condition, characterized by trigonocephaly, craniofacial anomalies and ID. Several different chromosome deletions and and point mutations in distinct genes have been associated with the disease in patients originally diagnosed as Opitz C. By whole exome sequencing we identified a de novo splicing mutation in FOXP1 in a patient, initially diagnosed as C syndrome, who suffers from syndromic intellectual disability with trigonocephaly. The mutation (c.1428 + 1 G > A) promotes the skipping of exon 16, a frameshift and a premature STOP codon (p.Ala450GLyfs*13), as assessed by a minigene strategy. The patient reported here shares speech difficulties, intellectual disability and autistic features with other FOXP1 syndrome patients, and thus the diagnosis for this patient should be changed. Finally, since trigonocephaly has not been previously reported in FOXP1 syndrome, it remains to be proved whether it may be associated with the FOXP1 mutation., The authors thank the patient and his family for wholehearted collaboration. They are also grateful to M. Cozar for technical assistance, and to CNAG for exome sequencing within the “300 exomes to elucidate rare diseases” program. Funding was from Associació Síndrome Opitz C, Terrassa, Spain; Spanish Ministerio de Economía y Competitividad (SAF2014-56562-R; SAF2016-75948-R, FECYT, crowdfunding PRECIPITA); ISCIII Ministerio de Economía y Competitividad (PT13/0001/0044), Catalan Government (2014SGR932) and from CIBERER (U720).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A roadmap to gene discoveries and novel therapies in monogenic low and high bone mass disorders

  • Formosa, Melissa M.
  • Bergen, Dylan J.M.
  • Gregson, Celia L.
  • Maurizi, Antonio
  • Kämpe, Anders
  • Garcia Giralt, Natàlia
  • Zhou, Wei
  • Grinberg, Daniel
  • Ovejero Crespo, Diana
  • Zillikens, M. Carola
  • Williams, Graham R.
  • Bassett, J.H. Duncan
  • Brandi, María Luisa
  • Sangiorgi, Luca
  • Balcells, Susana
  • Högler, Wolfgang
  • Van Hul, Wim
  • Mäkitie, Outi
Genetic disorders of the skeleton encompass a diverse group of bone diseases differing in clinical characteristics, severity, incidence and molecular etiology. Of particular interest are the monogenic rare bone mass disorders, with the underlying genetic defect contributing to either low or high bone mass phenotype. Extensive, deep phenotyping coupled with high-throughput, cost-effective genotyping is crucial in the characterization and diagnosis of affected individuals. Massive parallel sequencing efforts have been instrumental in the discovery of novel causal genes that merit functional validation using in vitro and ex vivo cell-based techniques, and in vivo models, mainly mice and zebrafish. These translational models also serve as an excellent platform for therapeutic discovery, bridging the gap between basic science research and the clinic. Altogether, genetic studies of monogenic rare bone mass disorders have broadened our knowledge on molecular signaling pathways coordinating bone development and metabolism, disease inheritance patterns, development of new and improved bone biomarkers, and identification of novel drug targets. In this comprehensive review we describe approaches to further enhance the innovative processes taking discoveries from clinic to bench, and then back to clinic in rare bone mass disorders. We highlight the importance of cross laboratory collaboration to perform functional validation in multiple model systems after identification of a novel disease gene. We describe the monogenic forms of rare low and high rare bone mass disorders known to date, provide a roadmap to unravel the genetic determinants of monogenic rare bone mass disorders using proper phenotyping and genotyping methods, and describe different genetic validation approaches paving the way for future treatments., Funding was obtained from the GEMSTONE COST Action (CA18139). MMF has received research funds from The University of Malta Research, Innovation and Development Trust and The Malta Community Chest Fund, and the Research Excellence Programme (REP-2020-011; Project GeOM financed by the Malta Council for Science & Technology, for and on behalf of the Foundation for Science and Technology, through the Research Excellence Programme). DB is funded by the Foundation Fellowship from Versus Arthritis (Grant no. 22044). NG-G and DC are supported by CIBERFES (CB16/10/00245 [ISCIII]), FEIOMM2019 and European Regional Development Fund (ERDF). WZ is funded by the Jaap Schouten Foundation (The Netherlands). WVH received a Methusalem-OEC grant for the project “GENOMED” and a Research Fund of the University of Antwerp (FFB190208). MB has received funding from La Fondazione Italiana Ricerca sulle Malattie dell’Osso. The Origins of Bone and Cartilage Disease Programme analysed the skeletal phenotype of knockout mice generated by the International Mouse Phenotyping Consortium (IMPC) and was funded by a Wellcome Trust Strategic Award (101123) to GW and JB. OM is funded by the Sigrid Jusélius Foundation. DG and SB declare that this study received funding from MINECO (SAF2016-75948R and PID2019-107188RB-C21). The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Expression profiling of microRNAs in human bone tissue from postmenopausal women

  • Ugarte Corbalán, Laura de, 1988-
  • Serra-Vinardell, Jenny
  • Nonell Mazelon, Lara, 1972-
  • Balcells, Susana
  • Arnal, Magdalena
  • Nogués Solán, Xavier
  • Mellibovsky, Leonardo
  • Grinberg, Daniel
  • Díez Pérez, Adolfo
  • Garcia Giralt, Natàlia
Bone tissue is composed of several cell types, which express their own microRNAs (miRNAs) that will play a role in cell function. The set of total miRNAs expressed in all cell types configures the specific signature of the bone tissue in one physiological condition. The aim of this study was to explore the miRNA expression profile of bone tissue from postmenopausal women. Tissue was obtained from trabecular bone and was analyzed in fresh conditions (n = 6). Primary osteoblasts were also obtained from trabecular bone (n = 4) and human osteoclasts were obtained from monocyte precursors after in vitro differentiation (n = 5). MicroRNA expression profiling was obtained for each sample by microarray and a global miRNA analysis was performed combining the data acquired in all the microarray experiments. From the 641 miRNAs detected in bone tissue samples, 346 (54%) were present in osteoblasts and/or osteoclasts. The other 46% were not identified in any of the bone cells analyzed. Intersection of osteoblast and osteoclast arrays identified 101 miRNAs shared by both cell types, which accounts for 30-40% of miRNAs detected in these cells. In osteoblasts, 266 miRNAs were detected, of which 243 (91%) were also present in the total bone array, representing 38% of all bone miRNAs. In osteoclasts, 340 miRNAs were detected, of which 196 (58%) were also present in the bone tissue array, representing 31% of all miRNAs detected in total bone. These analyses provide an overview of miRNAs expressed in bone tissue, broadening our knowledge in the microRNA field., This work was supported by the Red Temática de Investigación Cooperativa en Envejecimiento y Fragilidad (RETICEF; RD12/0043/0022) and Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES; CB16/10/00245), and the Grants PI10/01537, PI13/00116, and PI13/00444 from FIS (Carlos III Health Institute, Science and Innovation Ministry); SAF2016-75948-R, from Ministerio de Economia y Competitividad, and 2014SGR-932 from Generalitat de Catalunya. FEDER funds also supported this study.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Common and rare variants of WNT16, DKK1 and SOST and their relationship with bone mineral density

  • Martínez-Gil, Núria
  • Roca Ayats, Neus
  • Monistrol-Mula, Anna
  • Garcia Giralt, Natàlia
  • Diez Pérez, Adolfo
  • Nogués Solán, Xavier
  • Mellibovsky, Leonardo
  • Grinberg, Daniel
  • Balcells, Susana
Numerous GWAS and candidate gene studies have highlighted the role of the Wnt pathway in bone biology. Our objective has been to study in detail the allelic architecture of three Wnt pathway genes: WNT16, DKK1 and SOST, in the context of osteoporosis. We have resequenced the coding and some regulatory regions of these three genes in two groups with extreme bone mineral density (BMD) (n = ∼50, each) from the BARCOS cohort. No interesting novel variants were identified. Thirteen predicted functional variants have been genotyped in the full cohort (n = 1490), and for ten of them (with MAF > 0.01), the association with BMD has been studied. We have found six variants nominally associated with BMD, of which 2 WNT16 variants predicted to be eQTLs for FAM3C (rs55710688, in the Kozak sequence and rs142005327, within a putative enhancer) withstood multiple-testing correction. In addition, two rare variants in functional regions (rs190011371 in WNT16b 3'UTR and rs570754792 in the SOST TATA box) were found only present in three women each, all with BMD below the mean of the cohort. Our results reinforce the higher importance of regulatory versus coding variants in these Wnt pathway genes and open new ways for functional studies of the relevant variants., We thank M. Pineda, N. Stender, R. Urreizti and M. Cozar for relevant technical assistance. Funds for the study include grants SAF2014-56562-R and SAF2016-75948-R (Spanish MINECO), and CIBERER (U720). NMG is a recipient of a FI predoctoral fellowship from Generalitat de Catalunya; NRA is a recipient of a FPU predoctoral fellowship from the Spanish Ministerio de Educación Cultura y Deporte.